Lawrence Mertz
Chief Tech/Sci/R&D Officer bei ACCELERATE DIAGNOSTICS, INC.
Profil
Lawrence Mertz is currently the Chief Technology Officer at Accelerate Diagnostics, Inc. He previously worked as the SVP-Clinical Operations, Research & Development at Meridian Bioscience, Inc. and as the Vice President-Research & Development, Engineering at Biora Therapeutics, Inc. Dr. Mertz obtained his undergraduate and doctorate degrees from the State University of New York at Buffalo.
Aktive Positionen von Lawrence Mertz
Unternehmen | Position | Beginn |
---|---|---|
ACCELERATE DIAGNOSTICS, INC. | Chief Tech/Sci/R&D Officer | 01.05.2021 |
Ehemalige bekannte Positionen von Lawrence Mertz
Unternehmen | Position | Ende |
---|---|---|
BIORA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | - |
MERIDIAN BIOSCIENCE, INC. | Chief Tech/Sci/R&D Officer | - |
Ausbildung von Lawrence Mertz
State University of New York at Buffalo | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
ACCELERATE DIAGNOSTICS, INC. | Health Technology |
BIORA THERAPEUTICS, INC. | Health Services |
Private Unternehmen | 1 |
---|---|
Meridian Bioscience, Inc.
Meridian Bioscience, Inc. Miscellaneous Commercial ServicesCommercial Services Meridian Bioscience, Inc. engages in the development, production, sale, and distribution of diagnostic products. Its platforms include molecular, immunoassay, urea breath, and blood chemistry. It operates through the Diagnostics and Life Science segments. The Diagnostics segment consists of manufacturing operations for infectious disease and blood chemistry products and the sale and distribution of diagnostics products domestically and abroad. The Life Science segment distributes bulk antigens, antibodies, polymerase chain reaction/ quantitative PCR reagents, nucleotides, competent cells, and bioresearch reagents used by researchers, agri-bio companies, and other diagnostic manufacturing companies. The company was founded by William J. Motto in 1976 and is headquartered in Cincinnati, OH. | Commercial Services |